Negotiated lower Medicare costs for 10 popular prescription drugs went into effect Thursday. How much those savings will be passed on to Medicare Part D an ...

Bristol Myers Squibb's financial results haven't been great in recent years. The giant drugmaker has been facing challenges, ...

Curing Stomach Cancer (DDF) proudly concludes a transformative year shaped by expanded programming, strengthened global partnerships, and a renewed commitment to serving patients and families facing ...

Initial deployment at three pilot Amazon Grocery fulfillment facilities in North America exceeded expectations, achieving ...

Dallas, this week highlighted progress under the Trump Administration to lower prescription drug prices, following recent commitments from pharmaceutical manufacturers to adopt Most Favored Nation ...

Hyderabad: Union Minister of State for Home Affairs Bandi Sanjay Kumar participated in the inauguration ceremony of the newly ...

Detailed price information for Astrazeneca Plc ADR (AZN-Q) from The Globe and Mail including charting and trades.

Bristol Myers Squibb (BMS) has yet to announce official presentation plans at the 44 th annual JP Morgan Healthcare Conference, although Karin Shanahan, EVP, chief supply chain and operations officer, ...

For H1 2025 Lloyd’s posted a £4.2bn ($5.6bn) H1 profit before tax which Tiernan called a “solid half-year performance, demonstrating strength and resilience”. This was down £700mn year on year, as ...

Bristol Myers Squibb (BMY) is undervalued and poised for growth, with strong dividends and robust financials. Read here for ...

India’s EV push and renewable expansion are accelerating lithium battery demand. This overview explains why the sector offers a decade-long growth runway and what investors should ...

Why it matters: Fourteen companies in total have now reached what the administration calls most-favored-nation pricing deals. They agreed to charge the U.S. government no more for new drugs than the ...